Quantcast Nonbarbiturate sedative and hypnotics - Pharmacology I

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
c.
Intermediate-Acting Barbiturates.
(1)  Basic information. Intermediate-acting barbiturates have a duration of
action that lasts from 4 hours to 6 hours. These agents are mainly use for the initial and
short-term treatment of insomnia.
Example of intermediate-acting barbiturate. Amobarbital (Amytal).
(2)
d.
Long-Acting Barbiturates.
(1)  Basic information. Long-acting barbiturates have a duration of action
that lasts from 6 hours to 8 hours. These agents are used orally to maintain daylong
sedation in anxiety-tension states. Furthermore, long-acting barbiturates are useful in
the treatment of various convulsive disorders.
(2)
Examples of long-acting barbiturates.
(a)
Phenobarbital.
Mephobarbital (Mebaral).
(b)
7-9. NONBARBITURATE SEDATIVES AND HYPNOTICS
a.
Short-Acting Agents.
(1)  Background information. Short-acting nonbarbiturate sedative-hypnotics
are generally used orally in the initial and short-term treatment of insomnia.
(2)
Examples of short-acting nonbarbiturate sedative-hypnotics.
(a)  Chloral hydrate (Noctec). Drug interactions may occur between
chloral hydrate and anticoagulants, furosemide, alcohol, or other drugs that are CNS
depressants.
(b)  Triazolam (Halcion). Triazolam is rapidly absorbed through the
oral route and is as effective as the barbiturates in inducing sleep. It is excreted in
breast milk and should not be administered to nursing mothers.
b.
Intermediate-Acting Agents.
(1)  Background information. Intermediate-acting nonbarbiturate agents are
administered orally to effectively control moderate to severe daytime anxiety and
tension in patients who have neuroses and mild depressive states.
(2)
Examples of intermediate-acting nonbarbiturates.
MD0804
7-8



Medical News
ESC on SIGNIFY: No Comment
BARCELONA (MedPage Today) -- The results of SIGNIFY, a study...
medpagetoday.com
Firm Date for ICD-10 Switch Still Not Raising Urgency
WASHINGTON (MedPage Today) -- Although there is a firm date...
medpagetoday.com
ESC: Gout Drug Some Help in Heart Surgery (CME/CE)
BARCELONA (MedPage Today) -- Giving the gout drug colchicine perioperatively...
medpagetoday.com
ESC: Novel Heart Failure Drug a Game-Changer (CME/CE)
(MedPage Today) -- An investigational heart failure drug being developed...
medpagetoday.com
Tax forms could pose challenge for HealthCare.gov
If you got health coverage through President Barack Obama's law...
medicalxpress.com
Sudden death predictor identifies ICD candidates in new ESC Guidelines
Saturday 30 August 2014: A new sudden death predictor for...
medicalxpress.com
The early cost of HIV: Inflammatory response breaks down intestinal lining, but help may come from friendly bacteria
Researchers at UC Davis have made some surprising discoveries about...
medicalxpress.com
First expert consensus on ventricular arrhythmias published
The first expert consensus on ventricular arrhythmias is published today....
medicalxpress.com
First comprehensive ESC Guidelines on aortic diseases published
The first comprehensive ESC Guidelines on aortic diseases are published...
medicalxpress.com
First recommendations on all new oral anticoagulants in pulmonary embolism published
The first recommendations on the use of all new oral...
medicalxpress.com
First multidisciplinary recommendations on management of arrhythmias in ACS patients
The first multidisciplinary recommendations on the management of arrhythmias in...
medicalxpress.com
ESC/EACTS revascularization guidelines stress benefit of revascularization in stable CAD
The therapeutic benefit of revascularisation in coronary artery disease (CAD)...
medicalxpress.com
Study shows cavities have become the most common childhood disease
A Washington Post blog entry published earlier this week reports...
scopeblog.stanford.edu
Study shows cavities have become the most common childhood disease
A Washington Post blog entry published earlier this week reports...
scopeblog.stanford.edu
CMS Shuts Down Sunshine Act Database -- Again
WASHINGTON (MedPage Today) -- The Centers for Medicare and Medicaid...
medpagetoday.com
Tweet of the Week: Where We Donate vs. What Kills Us
(MedPage Today) -- Welcome to another edition of the MedPage...
medpagetoday.com
ZMapp Ebola Drug Effective in Macaques (CME/CE)
(MedPage Today) -- A controversial cocktail of Ebola antibodies was...
medpagetoday.com
Friday Feedback: VA Lessons
(MedPage Today) -- In hindsight, what are the real lessons...
medpagetoday.com
This Week: Publication Bias, Lagging FDA
(MedPage Today) -- A study on publication bias, a lagging...
medpagetoday.com
MOC Watch: CRNA Version Raises Hackles
(MedPage Today) -- Doctors are up in arms about maintenance...
medpagetoday.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +